CHEMICAL PREPARATIONS PHARMACEUTICAL USE

Brand Owner (click to sort) Address Description
BUCHEM BV BUCHEM B.V. Minden 60 NL-7327 AW Apeldoorn Netherlands Chemical preparations for pharmaceutical use; chemical preparations for medical purposes; chemical preparations for veterinary purposes;The color(s) green and dark blue is/are claimed as a feature of the mark.;Chemicals used in science; chemical preparations for use in industry; chemicals used in agriculture, horticulture and forestry; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemicals for use in chromatography;Scientific and technological services and research and development relating thereto; chemical research and analysis services; scientific and technological analysis; scientific laboratory services; chemical laboratories; analytical laboratory services;
GAMMARICH Davos Life Science Pte. Ltd. 11 Biopolis Way, Helios #07-03 Singapore 138667 Singapore Chemical preparations for pharmaceutical use and pharmaceutical and chemico-pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, inflammatory diseases, and the improvement and maintenance of cellular health; medicated skin care and hair care preparations for pharmaceutical use in the treatment and prevention of skin cancer, inflammatory diseases, and for UV protection; natural pharmaceutical preparations for use in the treatment of cancer, cardiovascular diseases, inflammatory diseases, skin care, hair care, UV protection, and the improvement and maintenance of cellular health; nutritional supplements; vitamin supplements; food supplements for medical purposes; dietetic foods adapted for medical use; medicated nutritional additives for medical purposes for use in foods for human consumption; mineral food-supplements; natural nutritional oils for medical purposes and not for food or cosmetic purposes; oils for pharmaceutical purposes for use in the treatment of cancer, cardiovascular diseases, inflammatory diseases, skin care, hair care, UV protection, and the improvement and maintenance of cellular health; medicated grooming preparations for pets and livestock for use in skin care and hair care for veterinary use; medicated dietary supplements for animals; medicated dietetic foodstuffs for animals for medical use; medicated nutritional additives for animal foodstuffs; medicated supplements for animal foodstuffs; vitamin and mineral premixes, nutritional supplements in the nature of probiotic compositions, and tocotrienols-based pharmaceutical preparations for use to enhance immunity and fertility for animals; preparations consisting of vitamins; vitamins; vitamins, namely, tocotrienols and tocotrienols-based preparations for use in the manufacture of cosmetics;Cosmetic preparations; non-medicated skincare cosmetics; non-medicated skincare preparations for cosmetic use; non-medicated facial skin care products for cosmetic use; facial creams for cosmetic use; facial lotions for cosmetic use; facial masks for cosmetic use; facial skin moisturizers for cosmetic use; facial cosmetic preparations; facial scrubs for cosmetic use; facial skin toners; facial washes for cosmetic use; skin moisturizers for cosmetic use; moisturizing body lotion for cosmetic use; moisturizing creams for cosmetic use; moisturizing gels for cosmetic use; moisturizing lotions for cosmetic use; moisturizing cosmetic preparations; moisturizing skin creams for cosmetic use; moisturizing skin lotions for cosmetic use; oil for cosmetic use; non-medicated grooming preparations for pets and livestock in the nature of cosmetics; shampoos for animals; non-medicated toiletries for the care of the skin of domestic animals; essential oils for use in food;GAMMA RICH;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.